Morepen Bags ₹2825 Crore Global Deal, Expands into High-Growth CDMO Segment

Morepen Laboratories Ltd has secured a ₹2825 Crore (USD 91 million) global order from a leading pharma major under a CDMO arrangement. The supplies are expected to commence within the next 4-5 months, with execution scheduled through Q1 of the following fiscal year, subject to customary operational and regulatory approvals. The order is expected to be executed within a period of approximately 12-15 months from the date of award. This international commercial supply contract falls under a CDMO arrangement and is not a related party transaction.